MEDP: Medpace Holdings Average Forecast Price

Corporate company logo of Medpace Holdings (MEDP)

Medpace Holdings, Inc. (MEDP) creates a closed ecosystem for small biotech firms, where stringent FDA controls render their IT infrastructure mission-critical. The business relies on a comprehensive service suite for small startups, allowing the company to maximize profits. The current metric stands at 672.63. This chart on GURU.Markets illustrates the price action of a company developing strategic partnerships to accelerate the time-to-market for new drugs.

MEDP (Medpace Corp) Price Target Chart history from 07/04/2022 to 11/12/2026

Analytical breakdowns for Medpace Inc. (MEDP)

- market price and analyst price targets:
Stock Quotes medpace.com|MEDP - Analyst Consensus Forecast
- market capitalization information:
Market Value Medpace Inc.|MEDP - Enterprise Value
- shareholders' equity book value data:
Equity per Share Medpace|MEDP - Company Book Value|Market Capitalization to Net Assets medpace.com|MEDP - Aggregate Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Equity Medpace Holdings, Inc.|MEDP - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Medpace Corp|MEDP - Company Aggregate Debts|Debts to Book Capitalization Medpace Inc.|MEDP - Company Long-Term Debt|Company Short-Term Loans and Borrowings Medpace|Quick Liquidity Indicator medpace.com
- net income and valuation multiples indicators:
MEDP - Net Profit|Projected Future Earnings Medpace Holdings, Inc.|MEDP - Price to Earnings Ratio|Future Price to Earnings Multiple Medpace Holdings|MEDP - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Medpace Inc.|MEDP - Operating profit EBITDA|Net earnings per one share for the last twelve months Medpace|MEDP - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months medpace.com|MEDP - Net earnings per share growth this year|Projected earnings per share increase next year Medpace Holdings, Inc.
General company analysis:MEDP medpace.com
Flagship merchandise of Medpace Corp

Rising demand from biotech startups for comprehensive R&D outsourcing creates a foundation for the steady expansion of the Medpace Holdings, Inc. (MEDP) client base. By analyzing the target market consensus dynamics, an investor can see a weighted average share price valuation from leading institutions that measures the asset's expected fair value. This allows for an assessment of the investment's margin of safety and confirms the business's resilience to market volatility.

Competitors of Medpace Holdings, Inc.

Consensus Target iqvia.com IQV|Analyst Consensus Forecast LH (Labcorp)|ICON plc (ICLR) - Average Forecast Price|Charles River Lab - Analyst Consensus Forecast|EVO (Evotec Group) - Broker Consensus Forecast|Fortrea Holdings Inc. (FTRE) - Price Target Chart|Forecast Levels Chart LFCR (Lifecore Biomedical, Inc.)|Price Target Chart OmniAb|Inotiv Inc - Forecast Levels Chart|Analyst Consensus Forecast CDMO|CTLT (Catalent, Inc) - Fair Value Consensus|Analyst Consensus Forecast SCPX (Scorpius Holdings, Inc.)